(Q36403838)

14 August 2017

Relationship between serum CA19-9 and CEA levels and prognosis of pancreatic cancer (English)

1 reference

14 August 2017

1 reference

Lei Wu

1

1 reference

14 August 2017

Peijun Huang

2

1 reference

14 August 2017

Fang Wang

3

1 reference

14 August 2017

Daqian Li

4

1 reference

14 August 2017

Erfu Xie

5

1 reference

14 August 2017

Yan Zhang

6

1 reference

14 August 2017

Shiyang Pan

7

1 reference

14 August 2017

language of work or name

1 reference

1 December 2015

1 reference

Annals of Translational Medicine

14 August 2017

1 reference

14 August 2017

3

1 reference

14 August 2017

21

1 reference

14 August 2017

328

1 reference

Serum CA 19-9 and CEA levels as a prognostic factor in pancreatic adenocarcinoma

14 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4690989

Cancer statistics for Hispanics/Latinos, 2012.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4690989

30 September 2017

Cancer statistics, 2010

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4690989

Epidemiology of pancreatic cancer

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4690989

Early detection of pancreatic carcinoma

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4690989

Serum CA242, CA199, CA125, CEA, and TSGF are Biomarkers for the Efficacy and Prognosis of Cryoablation in Pancreatic Cancer Patients

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4690989

Increase diagnostic accuracy in differentiating focal type autoimmune pancreatitis from pancreatic cancer with combined serum IgG4 and CA19-9 levels.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4690989

Diagnostic value of serum carbohydrate antigen 19-9 in pancreatic cancer: a meta-analysis

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4690989

A preoperative serum signature of CEA+/CA125+/CA19-9 ≥ 1000 U/mL indicates poor outcome to pancreatectomy for pancreatic cancer

21 September 2018

1 reference

12 December 2020

The clinical value of serum CEA, CA19-9, and CA242 in the diagnosis and prognosis of pancreatic cancer

1 reference

12 December 2020

[Clinical analysis of 2340 cases of pancreatic cancer]

1 reference

12 December 2020

Carbohydrate antigen 19.9 accurately selects patients for laparoscopic assessment to determine resectability of pancreatic malignancy

1 reference

12 December 2020

Clinical evaluation of combined use of CEA, CA19-9 and CA50 in the serum of patients with pancreatic carcinoma

1 reference

12 December 2020

10.3978/J.ISSN.2305-5839.2015.11.17

Identifiers

DOI

1 reference

14 August 2017

1 reference

14 August 2017

PubMed publication ID

26734638

1 reference